A Study on the Dynamics and Grading Criteria Construction of Adverse Reactions to ATG/ALG Therapy in Aplastic Anemia
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This prospective, single-center, observational cohort study aims to systematically observe and describe the clinical characteristics of adverse reactions in patients with aplastic anemia undergoing ATG (Anti-Thymocyte Globulin) /ALG (Anti-Lymphocyte Globulin) treatment, providing a data foundation for the development of relevant management strategies. This study plans to enroll 200 aplastic anemia patients undergoing ATG/ALG treatment
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Meet the diagnostic criteria for aplastic anemia (Camitta criteria);
• Receiving ATG/ALG immunosuppressive therapy for the first time;
Locations
Other Locations
China
Regenerative Medicine Center and Red Blood Cell Disorders Center
RECRUITING
Tianjin
Contact Information
Primary
Weiwang Li, PhD
liweiwang@ihcams.ac.cn
15332132036
Time Frame
Start Date: 2026-02-23
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 200
Treatments
Patients with aplastic anemia undergoing ATG or ALG treatment
Related Therapeutic Areas
Sponsors
Leads: Institute of Hematology & Blood Diseases Hospital, China